Home/ICT/Artificial Intelligence/China AI for Predicting Pandemics and Global Health Emergencies Market

China AI for Predicting Pandemics and Global Health Emergencies Market - Strategic Insights and Forecasts (2026-2031)

The study analyzes China's AI for predicting pandemics and the global health emergencies industry landscape, innovation trends, and adoption dynamics.

$2,850
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

📞

Your data is secure. We do not share information with any third party.

China AI for Predicting Pandemics and Global Health Emergencies Market Report

Report IDKSI061618070
PublishedFeb 2026
Pages81
FormatPDF, Excel, PPT, Dashboard

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Frequently Asked Questions

The China AI for Predicting Pandemics and Global Health Emergencies market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 15.3%. This expansion is expected to result in the market reaching USD 0.76 billion in 2031, up from USD 0.38 billion in 2026.

The market's growth is primarily driven by the central government’s adoption of the 'AI+ Initiative' and the push for smart city development, which directly mandates AI integration into public infrastructure. Technologically, there's a strong demand for AI platforms capable of analyzing large-scale, heterogeneous data such as electronic health records, genomic sequences, and population mobility patterns for real-time disease surveillance.

The Chinese market exhibits a strong demand for software-as-a-service (SaaS) models, necessitated by the need for real-time data processing and cloud-based elastic computational resources for analyses like genomic sequencing. Additionally, leading domestic firms are integrating proprietary medical knowledge graphs with open-source large language models (LLMs) to address complex clinical and public health scenarios.

Leading domestic technology firms are consolidating their market positions by integrating proprietary medical knowledge graphs with open-source large language models (LLMs). This strategic approach significantly enhances their capacity to tackle intricate clinical and public health challenges, leveraging advanced domestic technological capabilities.

Regulatory focus in China is shifting towards standardized and accountable AI deployment, with the National Health Commission (NHC) prioritizing specific frameworks. These frameworks emphasize data quality, model transparency, and equitable deployment to build confidence in AI-powered decision support systems within public health infrastructure.

Stemming from recent global health events, China has positioned artificial intelligence as a foundational technology, not merely a supplementary tool, within its public health infrastructure. The national strategy emphasizes leveraging digital intelligence and data-driven governance models to effectively manage future health risks, creating sustained demand for verifiable, high-accuracy AI solutions.

Need data specifically for your business?Request Custom Research →

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon